Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Trehalose,Nattokinase,Rutin
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
NOVOS Launches Daily Chew to Optimize and Maintain Essential Organ Function
Details : Novos vital is a groundbreaking supplement chew scientifically formulated with an ingredient blend shown to support and optimize essential organ functions that decline with age.
Product Name : Novos Vital
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
February 21, 2024
Lead Product(s) : Trehalose,Nattokinase,Rutin
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Hepatitis B Vaccine (Recombinant Dna)
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Proof Of Concept : Immunogenicity and Safety of hepB Injection in the Dermis Using VAX-ID
Details : Undisclosed
Product Name : HBVaxPro
Product Type : Vaccine
Upfront Cash : Inapplicable
July 10, 2014
Lead Product(s) : Hepatitis B Vaccine (Recombinant Dna)
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable